文献速递类风湿关节炎

类风湿关节炎残留症状与未满足需求的系统文献综述

Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2021-09-09

该系统综述检索了2008年至2018年的文献,纳入55篇(53项独特研究,含10项随机对照试验),评估达到治疗目标的类风湿关节炎患者的残留疾病负担。研究发现,达到低疾病活动度或缓解的部分患者仍存在残留症状,最常报告的功能残疾、关节压痛/肿胀、疼痛、患者总体评估和疲劳,尤其疼痛、疲劳和功能改善存在未满足需求。

要点

  • 达到低疾病活动度或缓解的RA患者仍可报告残留症状。
  • 残留症状比例因LDA或缓解定义不同而异,LDA患者报告更常见。
  • 最常报告结局为功能残疾、关节压痛/肿胀、疼痛、患者总体评估和疲劳。

核心结论

  • 部分RA患者虽达到LDA或缓解,但仍存在残留症状,提示疼痛、疲劳和功能方面存在未满足需求。

研究设计与样本

  • 检索Medline、Embase和Cochrane Library(2008年1月1日至2018年4月18日)的英文前瞻性和回顾性研究,并筛选会议摘要(2016年1月至2018年4月)和相关研究参考文献。

主要发现

  • 共识别8339条记录,纳入55篇文献,包含53项独特研究,其中10项为随机对照试验。
  • 48项研究报告了达到LDA或缓解的患者情况。
  • 残留症状比例因LDA或缓解定义而异,LDA患者报告更常见。
  • 最常报告结局为功能残疾(34项研究)、关节压痛或肿胀(18项)、疼痛(17项)、患者总体评估(15项)和疲劳(14项)。
  • 少数研究报告了达到特定阈值的患者百分比,该阈值可用于定义残留症状的存在。

临床怎么用

  • 临床应关注达到治疗目标的RA患者仍可能存在的残留症状,尤其是疼痛、疲劳和功能损害。

局限性

  • 研究在人群、治疗目标和结局报告方面存在差异。
  • 残留症状比例因LDA或缓解定义不同而异。
  • 少数研究报告达到特定阈值的患者百分比。
  • 未来观察性研究需标准化报告以更好理解该问题。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the nature and burden of residual disease in rheumatoid arthritis (RA) in patients who meet treatment targets. Second, for those who did not meet targets, to evaluate how much is due to patient symptoms. METHODS: Prospective and retrospective studies were searched in Medline, Embase, and Cochrane Library in the English language from January 1, 2008 to April 18, 2018; conference abstracts (from January 2016 to April 2018) and reference lists of relevant studies were also screened. RESULTS: Of 8,339 records identified, 55 were included in the review; 53 were unique studies, including 10 randomized controlled trials. Of these, 48 reported on patients who achieved low disease activity (LDA) or remission. Studies varied in population, treatment goals, and outcome reporting. The proportions of patients with residual symptoms in these studies varied by the definitions used for LDA or remission and were more often reported in patients with LDA than those in remission. The most commonly reported outcome measures were functional disability (n = 34 studies), tender or swollen joints (n = 18), pain (n = 17), patient global assessment (n = 15), and fatigue (n = 14). However, few studies reported the percentage of patients achieving a specific threshold, which could then be used to easily define the presence of residual symptoms. CONCLUSION: Residual symptoms are present in some patients despite their achieving LDA or remission, highlighting an unmet need, especially with respect to improving pain, fatigue, and function. Standardized reporting in future observational studies would facilitate better understanding of this issue in defined RA populations.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Michaud K, Pope J, van de Laar M, et al. Systematic Literature Review of Residual Symptoms and an Unmet Need in Patients With Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021. PMID: 32619340. doi:10.1002/acr.24369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。